Disease	Advanced cancer/solid tumor only
Stage of Disease/Treatment	Metastatic/advanced
Prior Therapy	1 prior regimen
Type of Study – 1	Phase I
Type of Study – 2	Dose evaluation and cohort expansion
Primary Endpoint	Safety
Primary Endpoint	Tolerability
Secondary Endpoint	Efficacy
Investigator's Analysis	Drug tolerable, efficacy indeterminant